Sex differences in central stress response and Alzheimer's disease neuropathology
中枢应激反应和阿尔茨海默病神经病理学的性别差异
基本信息
- 批准号:9924147
- 负责人:
- 金额:$ 15.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:APP-PS1AcuteAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAnxietyAreaBehaviorBiochemicalBiologicalBrainCRF receptor type 1ChronicChronic stressClinical ResearchCorticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsCyclic AMP-Dependent Protein KinasesDataDevelopmentFemaleFundingHippocampus (Brain)HumanLinkMeasuresMemoryMental disordersMolecularMusNeuropathogenesisPKA inhibitorPathogenesisPathologyPathway interactionsPatternPhosphorylationPrefrontal CortexPrevention strategyProsencephalonSecond Messenger SystemsSenile PlaquesSex BiasSex DifferencesSignal PathwaySignal TransductionSocial isolationStressTestingTransgenic MiceViralViral VectorWomanWorkacute stressarrestin 2beta-arrestinbiological adaptation to stressdepressive symptomshigh riskin vivomalemenmouse modelneuropathologynoveloverexpressionparent grantpatient populationresponserestraint stresssexsexual dimorphismtransmission processtreatment strategy
项目摘要
Abstract
Clinical studies indicate that Alzheimer's disease (AD) disproportionately affects women more
than men, but the biological mechanisms underlying this sexual divergence are not well
understood. Convergent findings from our group and others indicate that stress contributes to
the pathogenesis of AD through its effects on corticotrophin releasing factor (CRF) transmission.
Recently we found that during stress, CRF coverts its function by triggering second messenger
signaling through the CRF receptor 1 (CRF1) favoring Gs-PKA signaling in females, while β-
arrestin-2 signaling is favored in males. This sex bias in CRF1 signaling likely results in different
phosphorylation patterns among downstream targets known to drive AD neuropathology and so
provides one mechanistic explanation for the difference in AD risk by sex. Consistent with this
mechanism, our preliminary data demonstrate that amyloid plaque development is much greater
in female than male transgenic mice in which both human APP and forebrain-restricted CRF are
overexpressed (APP+/CRF+/tTA+ mice) To continue this line of work, in this supplement, we
will study the molecular and cellular mechanisms underlying sex differences in psychiatric
disorders linked to AD pathogenesis and identifying the signaling pathways that may help
explain why stress affects females differently. The project proposed in the diversity supplement
directly ties to the funded parent grant (1 RF1 AG057884). We hypothesize that chronic stress
increases the risk of AD neuropathology in female transgenic mice due to sexual dimorphism in
downstream CRF1 signaling pathways and resultant AD related-protein phosphorylation, which
may be reversible with specific CRF1 antagonists or PKA inhibitors. To test our hypothesis, we
will confirm sex-divergent neuropathogenesis in mouse models of AD after acute and chronic
stress. We will test the memory and anxiety-depressive-like behaviors and biochemical
measures to determine the sex-specific vulnerability in APP/PS1 mice under chronic social
isolation stress and acute restraint stress. Then we will determine the sex-specific mechanistic
effects of CRF signaling impact on AD pathology. We will use viral vectors that overexpress
CRF in APP/PS1 mice in a brain area-specific manner to determine how the aforementioned
pathways are affected. Among the areas to be virally manipulated, the prefrontal cortex and
hippocampus will be targeted to determine the sex-specific downstream effects of CRF1
signaling in vivo. Finally, we will manipulate these pathways (PKA or β-arrestin-2) specifically.
This study will demonstrate plausible mechanisms that could explain the increased risk of AD in
women, and thus provide a mechanistic framework and novel targets for treatments of AD.
摘要
临床研究表明,阿尔茨海默病(AD)对女性的影响更大
但这种性别差异背后的生物学机制并不清楚,
明白我们小组和其他人的一致发现表明,压力有助于
通过影响促肾上腺皮质激素释放因子(CRF)的传递来研究AD的发病机制。
近年来我们发现,在应激状态下,CRF通过激活第二信使而实现功能转换
通过CRF受体1(CRF 1)的信号传导有利于女性中的Gs-PKA信号传导,而β-
抑制蛋白-2信号传导在男性中是有利的。CRF 1信号传导中的这种性别偏见可能导致不同的
已知驱动AD神经病理学的下游靶点之间的磷酸化模式,
为不同性别的AD风险差异提供了一种机制性解释。符合本
机制,我们的初步数据表明,淀粉样斑块的发展是更大的
在雌性比雄性转基因小鼠中,人APP和前脑限制性CRF均
过表达(APP+/CRF+/tTA+小鼠)为了继续这一系列工作,在本补充中,我们
将研究精神疾病中性别差异的分子和细胞机制。
与AD发病机制相关的疾病,并确定可能有助于
解释为什么压力对女性的影响不同。多样性补充中提出的项目
与资助的母基金直接相关(1 RF 1 AG 057884)。我们假设慢性压力
增加了雌性转基因小鼠中AD神经病理学的风险,这是由于雌性转基因小鼠中的性二态性。
下游CRF 1信号通路和由此产生的AD相关蛋白磷酸化,
可能是可逆的特异性CRF 1拮抗剂或PKA抑制剂。为了验证我们的假设,我们
将证实急性和慢性AD后小鼠模型中的性别差异神经发病机制
应力我们将测试记忆和焦虑抑郁样行为以及生化
测定APP/PS1小鼠在慢性社会应激下的性别特异性脆弱性的措施
隔离应激和急性束缚应激。然后我们将确定性别特异性机制
CRF信号传导对AD病理学的影响。我们将使用病毒载体,
CRF在APP/PS1小鼠的脑区特异性的方式,以确定如何上述
道路受到影响。在被病毒操纵的区域中,前额叶皮层和
海马将被靶向以确定CRF 1的性别特异性下游效应。
体内信号传导最后,我们将专门操纵这些通路(PKA或β-arrestin-2)。
这项研究将证明合理的机制,可以解释AD的风险增加,
女性,并因此提供了一个机制框架和新的目标治疗AD。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sex differences in CRF1, CRF, and CRFBP expression in C57BL/6J mouse brain across the lifespan and in response to acute stress.
- DOI:10.1111/jnc.15157
- 发表时间:2021-08
- 期刊:
- 影响因子:4.7
- 作者:Locci, Andrea;Yan, Yan;Rodriguez, Guadalupe;Dong, Hongxin
- 通讯作者:Dong, Hongxin
Sex Differences in the Phosphoproteomic Profiles of APP/PS1 Mice after Chronic Unpredictable Mild Stress.
- DOI:10.3233/jad-191009
- 发表时间:2020
- 期刊:
- 影响因子:4
- 作者:Dominguez, Sky;Rodriguez, Guadalupe;Fazelinia, Hossein;Ding, Hua;Spruce, Lynn;Seeholzer, Steven H.;Dong, Hongxin
- 通讯作者:Dong, Hongxin
Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.
- DOI:10.1016/j.psyneuen.2018.02.013
- 发表时间:2018-04
- 期刊:
- 影响因子:3.7
- 作者:Dong H;Keegan JM;Hong E;Gallardo C;Montalvo-Ortiz J;Wang B;Rice KC;Csernansky J
- 通讯作者:Csernansky J
Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.
APP/PS1 和衰老小鼠的神经炎症、小胶质细胞激活和蓝斑-去甲肾上腺素系统变性的比较。
- DOI:10.1186/s12974-020-02054-2
- 发表时间:2021-01-06
- 期刊:
- 影响因子:9.3
- 作者:Cao S;Fisher DW;Rodriguez G;Yu T;Dong H
- 通讯作者:Dong H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongxin Dong其他文献
Hongxin Dong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongxin Dong', 18)}}的其他基金
Epigenetic Regulation in Aging and Alzheimer's Disease
衰老和阿尔茨海默病的表观遗传调控
- 批准号:
10564831 - 财政年份:2022
- 资助金额:
$ 15.01万 - 项目类别:
Molecular Mechanisms Underlying Behavioral and Psychological Symptoms in Alzheimers Disease
阿尔茨海默病行为和心理症状的分子机制
- 批准号:
10452490 - 财政年份:2018
- 资助金额:
$ 15.01万 - 项目类别:
Molecular Mechanisms Underlying Behavioral and Psychological Symptoms in Alzheimers Disease
阿尔茨海默病行为和心理症状的分子机制
- 批准号:
9788262 - 财政年份:2018
- 资助金额:
$ 15.01万 - 项目类别:
Molecular Mechanisms Underlying Behavioral and Psychological Symptoms in Alzheimers Disease
阿尔茨海默病行为和心理症状的分子机制
- 批准号:
10183128 - 财政年份:2018
- 资助金额:
$ 15.01万 - 项目类别:
Age-Related Histone Modification Effect on Antipsychotic Action
年龄相关的组蛋白修饰对抗精神病作用的影响
- 批准号:
9281089 - 财政年份:2016
- 资助金额:
$ 15.01万 - 项目类别:
Age-Related Histone Modification Effect on Antipsychotic Action
年龄相关的组蛋白修饰对抗精神病作用的影响
- 批准号:
9077000 - 财政年份:2016
- 资助金额:
$ 15.01万 - 项目类别:
Aging and Antipsychotic Efficacy - Epigenetic Mechanisms
衰老和抗精神病药的功效——表观遗传机制
- 批准号:
8600189 - 财政年份:2012
- 资助金额:
$ 15.01万 - 项目类别:
Aging and Antipsychotic Efficacy - Epigenetic Mechanisms
衰老和抗精神病药的功效——表观遗传机制
- 批准号:
8445889 - 财政年份:2012
- 资助金额:
$ 15.01万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 15.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 15.01万 - 项目类别:
Operating Grants














{{item.name}}会员




